Jump to Navigation

Bextra Injury Attorneys

Bextra Removed From the Market Place

The FDA said recently that it is requiring Pfizer to remove Bextra from the U.S. market. After considering the findings of the FDA Advisory Committee, which met last February, the FDA determined that Bextra's overall risk versus benefit profile is unfavorable. Pfizer will also remove Bextra from European markets.

Studies released as recently as last December show a very high correlation between Bextra use and cardiovascular events such as heart attack and stroke. This risk is especially high in those that use the drug after having coronary artery by-pass surgery. Bextra is also strongly linked with a rare but deadly skin disorder called Stevens-Johnson's Syndrome.

We are encouraged that the FDA took this step to protect U.S. citizens. Hopefully this is a step towards the FDA reclaiming its position as a regulatory body committed to ensuring safe drugs on the market.

If you or a loved one experienced a heart attack, stroke, or serious blood clot while on Bextra, please contact an attorney immediately to discuss your legal rights.

Se Habla Espanol - Spanish Services Available

Contact Us

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Visit Our Other Sites:

  • Auto Lemon Law
  • Debt Relief
  • Social Security Disability

Our Office

Alex Simanovsky & Associates, LLC

2300 Henderson Mill Road NE
Suite 300
Atlanta, GA 30345

Phone: 678-781-1018
Toll Free: 866-865-3666
Email the Firm
Atlanta Law Office

  • Georgia Trial Lawyers Association Seal | GTLA | Collective Strength for Consumer Rights
  • The American Trial Lawyers Association Seal | The Association
  • ABA Seal
  • NCLC | National Consumer Law Center Seal
  • NACA Seal
  • BBB Seal